[Recent notions concerning the treatments used in multiple sclerosis (author's transl)]

[Recent notions concerning the treatments used in multiple sclerosis (author's transl)] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Recent notions concerning the treatments used in multiple sclerosis (author's transl)] Abstract Text:

[Recent notions concerning the treatments used in multiple sclerosis (author's transl)] Publishing Authors By Initials

For similar peptides: intercellular signaling peptides and proteins: cytokines: lymphokines: transfer factor research abstracts see: peptides: intercellular signaling peptides and proteins: cytokines: lymphokines: transfer factor research

PUBMED ID PMID:

MEDLINE DATE:

[Recent notions concerning the treatments used in multiple sclerosis (author's transl)] Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal belge de médecine physique et de réhabilit

VOLUME: 1

Page Numbers: 213-6

Journal Abbreviation:

ISSN: 0250-4766

DAY: 26

MONTH: 02

YEAR: 1978

[Recent notions concerning the treatments used in multiple sclerosis (author's transl)] Information

Number of References:

LANGUAGE: fre

NlmUniqueID: 7903309

[Recent notions concerning the treatments used in multiple sclerosis (author's transl)] Keywords Mesh Terms:

KEYWORDS: Transfer Factor

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: [Recent notions concerning the treatments used in multiple sclerosis (author's transl)] Information

Substance Name: Adrenocorticotropic Hormone

Registry Number: 9002-60-2

Grant and Affiliation Information for [Recent notions concerning the treatments used in multiple sclerosis (author's transl)]

AFFILIATION:

Country: BELGIUM

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Belge Med Phys Rehabil

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Recent notions concerning the treatments used in multiple sclerosis author's transl Related Publications

• Advances in ventriculography and myelography with the non-ionic constrast medium metrizamide.
• Biologic tolerance of the central nervous system to metrizamide.
• Cervical myelography with metrizamide by suboccipital puncture.
• Metrizamide as contrast medium for myelography and ventriculography. Preliminary clinical experiences.
• Review: Oxidative stress and excitotoxicity: a therapeutic issue in multiple sclerosis?
• Ventriculography with metrizamide.
• [Recent notions concerning the treatments used in multiple sclerosis (author's transl)]